Theranica Bio-Electronics, a Netanya, Israel-based medical device company offering a ‘smart’ patch that delivers neuromodulation therapy, closed its seed financing round of undisclosed amount.
Backers included a group of angel investors, led by entrepreneur and investor Dr. Shimon Eckhouse. In conjunction with the funding, Dr. Eckhouse will be serving as Chairman of the company.
Led by Alon Ironi, CEO and co-founder, Theranica is a medical device company that has combined neuromodulation therapy with wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The therapeutic ‘smart’ patches – which consist of a proprietary ‘smart’ chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin – are controlled by a smartphone app to allow for personalized and portable care.
The first application of the technology is for treatment of migraine headaches. Nerivio Migra addresses migraine headaches by providing neuromodulation therapy through a non-invasive, wearable, and disposable ‘smart’ patch. The product can be used at the onset of a migraine attack to provide pain relief, often eliminating pain.
The medical advisory board of the company includes:
– Professor David Yarnitsky, Professor of Neurology at the Technion Faculty of Medicine, Chief Editor of the PAIN Reports journal;
– Dr. Stephen Silberstein, Professor of Neurology and Director of the Jefferson Headache Center at Thomas Jefferson University as well as the former president of the American Headache Society, and
– Dr. Charles Argoff, Professor of Neurology at the Albany Medical College, Director of the Comprehensive Pain Center at the Albany Medical Center, President of the American Academy of Pain Medicine Foundation, and Co-Editor of the Neuropathic Pain Section of Pain Medicine.